Continuous-light Versus Pulsed-Light Accelerated Corneal Crosslinking with Ultraviolet-a and Riboflavin.

Yirui Zhu,Peter S. Reinach,Hanlei Zhu,Ling Li,Fan Yang,Jia Qu,Wei Chen
DOI: https://doi.org/10.1016/j.jcrs.2017.12.028
2018-01-01
Journal of Cataract & Refractive Surgery
Abstract:Purpose: To determine whether the pulsed-light ultraviolet-A (UVA) accelerated corneal crosslinking (CXL) procedure is more efficacious and selective than its continuous-light counterpart in rabbits. Setting: School of Ophthalmology and Optometry, Wenzhou Medical University, Wenzhou, Zhejiang, China. Design: Experimental study. Methods: Fifty-four rabbits were divided into 2 groups. Group 1 had continuous-light accelerated CXL using 9 mW/cm(2) UVA for 10 minutes (5.4 J/cm(2)). Group 2 had pulsed-light accelerated CXL by exposing them to 9 mW/cm(2) UVA for 20 minutes (1 second on/1 second off). Corneal stromal demarcation line depth, in vivo confocal microscopic analysis, biomechanical stiffness, endothelial cell density, and keratocyte apoptosis were measured after performing these CXL procedures. Results: The mean stromal demarcation line depth was 254.7 mu m +/- 47.4 (SD) in Group 1 and 341.1 +/- 36.1 mu m in Group 2 (P < .01). One day after CXL, confocal analysis and histological staining identified keratocyte apoptotic fragments in the anterior stroma in the Group 2 corneas whereas all cells were obliterated in Group 1. Seven days after treatment, the thicknesses in Group 1 were significantly greater than those in Group 2 (P < .05). Endothelial cell losses were reversible; however, in Group 1, some losses were still evident on day 7. Increases in both the stress-strain relationship and tangent modulus in Group 2 were greater than those in Group 1. Conclusion: The pulsed-light accelerated CXL protocol was less injurious and more efficacious at inducing CXL than the continuous-light accelerated CXL protocol in rabbit corneas. (C) 2018 ASCRS and ESCRS
What problem does this paper attempt to address?